Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
King
L E
LE
Vanderbilt University, Nashville, Tenn, USA.
Park
J H
JH
Adams
L B
LB
Olsen
N J
NJ
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy* / Q000378:metabolism*; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008137:Longitudinal Studies; D009682:Magnetic Resonance Spectroscopy; D008727:Methotrexate / Q000627:therapeutic use; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D010759:Phosphorus Isotopes; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D010710:Phosphates; D010759:Phosphorus Isotopes; D010725:Phosphocreatine; D006886:Hydroxychloroquine; D000255:Adenosine Triphosphate; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate